More interestingly, the apoptosis-inducing activity of fetuin-A has also been observed in cancer cell lines, such as mouse P388 leukemia and PC-3 prostate cancer models, with no effect on normal cell lines, suggesting its potential use as a selective anticancer agent. Here, AHSG is linked to cancer.